A Clinical Study to Evaluate Safety of the ExAblate 2100 UF V2 System in the Treatment of Symptomatic Uterine Fibroids
NCT01092988
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
40
Enrollment
INDUSTRY
Sponsor class
Conditions
Uterine Fibroids
Bleeding
Pain
Interventions
DEVICE:
Exablate 2100
Sponsor
InSightec